Golden
Stem Cell Theranostics

Stem Cell Theranostics

A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.

All edits

Edits on 5 Apr 2019
Dawson Sewell
Dawson Sewell edited on 5 Apr 2019 1:15 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 4 Apr 2019
Dawson Sewell
Dawson Sewell edited on 4 Apr 2019 11:02 pm
Edits made to:
Infobox (+1 properties)

Infobox

Industry
Dawson Sewell
Dawson Sewell edited on 4 Apr 2019 10:39 pm
Edits made to:
Infobox (+2 properties)
Article (+342/-21 characters)

Article

Stem Cell Theranostics is a biotechnology company using stem cells to treat cardiovascular diseases that is headquartered in Redwood City, California and was founded in 2013 by Anderw Lee. 



Stem CellThe Theranosticscompany seeks to address patient-specific pathophysiology based on the patient’s genetic profile. The company has a relationship with Stanford Cardiovascular Institute with which they developed their discovery platform that can be used to develop genetically-targeted therapies while also addressing cardiotoxicity. 

...

Funding

Series

On January 1, 2014 Stem Cell Theranostics completed their series A funding round with $5.5 million in funding from Bill Marcus. 

Infobox

Edits on 14 Mar 2019
Dawson Sewell
Dawson Sewell edited on 14 Mar 2019 3:53 pm
Edits made to:
Infobox (+8 properties)
Further reading (+8 cells) (+571 characters)
Documentaries, videos and podcasts (+3 cells) (+120 characters)

Further reading

Title
Author
Link
Type

Stem Cell Theranostics and Thermo Fisher Scientific Announce Collaboration to Advance Cardiomyopathy Disease Modeling Workflows

Stem Cell Theranostics Inc

Web

Stem Cell Theranostics secures "freedom to operate" in IP deal with GE Healthcare

Gareth Mcdonald

Web

Documentaries, videos and podcasts

Title
Date
Link

stem cell theranostics Archives - Stem Cell Podcast

August 18, 2015

Infobox

Edits on 31 Jan 2019
Meredith Hanel
Meredith Hanel edited on 31 Jan 2019 2:28 pm
Edits made to:
Infobox (+4/-2 properties)
Description (+288/-15 characters)
Article (+615 characters)
People (+8 cells) (+96 characters)
Categories (+2 topics)
Related Topics (+1 topics)
Topic thumbnail

Stem Cell Theranostics

Biotech company

A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.

Article

Stem Cell Theranostics seeks to address patient-specific pathophysiology based on the patient’s genetic profile. The company has a relationship with Stanford Cardiovascular Institute with which they developed their discovery platform that can be used to develop genetically-targeted therapies while also addressing cardiotoxicity. 

...

Divya Nag and fellow student Andrew Lee started Stem Cell Theranostics with their professors. Nag is no longer with Stem Cell Theranostics, and has started StartX Med, a medical arm of Standford Student Enterprises Labs and now works for Apple in the Health Special Projects section. 

People

Name
Role
Related Golden topics

Joseph C. Wu M.D., Ph.D., FACC

Founder



Andrew Lee

Founder



Divya Nag

Founder



Robert C. Robb Jr.

Founder



Infobox

Categories

Related Topics

Edits on 13 Sep 2018
Golden AI"Import structured data from Wikidata.org: https://www.wikidata.org/wiki/Q18636624"
Golden AI edited on 13 Sep 2018 6:40 am
Edits made to:
Infobox (+3 properties)
Edits on 1 Jan 2017
Golden AI"Initial topic creation"
Golden AI created this topic on 1 Jan 2017 12:00 am
Edits made to:
Description (+15 characters)
Article
Topic thumbnail

 Stem Cell Theranostics

Biotech company

No more activity to show.